Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NTLA
RXRX
Add up to 3 more stocks
NTLA
Intellia Therapeutics, Inc.
+1.16%
$12.26+0.14Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$1.71B
52W Range
$7.95 - $28.25
RXRX
Recursion Pharmaceuticals, Inc.
+1.23%
$4.12+0.05Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$2.16B
52W Range
$2.77 - $7.18
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.35 | 2.36 |
| P/S Ratio | 28.79 | 39.41 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 76.5% | -62.0% |
| Operating Margin | -651.7% | -867.9% |
| Net Margin | -672.2% | -945.9% |
| ROE | -55.0% | -56.7% |
| ROA | -46.7% | -42.8% |
| ROIC | -54.5% | -49.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 6.65 | 5.03 |
| Quick Ratio | 6.65 | 5.03 |
| Debt/Equity | 0.10 | 0.07 |
| Interest Coverage | N/A | -358.08 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.